These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12756713)

  • 1. [Scrutiny of drug marketing by drug industry].
    Perman E
    Lakartidningen; 2003 Apr; 100(16):1444-5. PubMed ID: 12756713
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physicians notify on drug industry's marketing].
    Perman E
    Lakartidningen; 2004 Mar; 101(11):1014-5. PubMed ID: 15055124
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulating manufacturer-affiliated communication in the information age.
    Schulman KA; Abernethy DR; Rathore SS; Woosley RL
    Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
    [No Abstract]   [Full Text] [Related]  

  • 4. [Written drug advertisements].
    Kormeset PO
    Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1946; author reply 1946-7. PubMed ID: 16915329
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physicians report verbal drug information. Cases scrutinized by the IGM].
    Perman E
    Lakartidningen; 2004 Aug; 101(35):2648, 2650. PubMed ID: 15458219
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pfizer urged to respond to criticism and participate in the public debate].
    Bengt J
    Lakartidningen; 2005 Feb 21-27; 102(8):574-5. PubMed ID: 15786910
    [No Abstract]   [Full Text] [Related]  

  • 7. [How to improve drug information!].
    Järhult B
    Lakartidningen; 1998 Jul; 95(30-31):3278-9. PubMed ID: 9715057
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical sales representatives and patient safety.
    Mintzes B; Lexchin J; Wilkes MS; Beaulieu MD; Reynolds E; Sutherland J; Durrieu G
    J Gen Intern Med; 2013 Nov; 28(11):1395. PubMed ID: 23897129
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceutical sales representatives and patient safety.
    Light DW
    J Gen Intern Med; 2013 Nov; 28(11):1394. PubMed ID: 23884603
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prohibited marketing and shift in meaning of indications--a case for the IGM].
    Perman E
    Lakartidningen; 2003 Jul; 100(28-29):2378-9. PubMed ID: 12899031
    [No Abstract]   [Full Text] [Related]  

  • 11. [What is happening with the institution for drug information scrutiny?].
    Håkansson J; Hensjö LO
    Lakartidningen; 1997 Jun; 94(24):2259-60. PubMed ID: 9213698
    [No Abstract]   [Full Text] [Related]  

  • 12. [A bribe to be at a drug industry-consultant's disposal?].
    Hernborg A
    Lakartidningen; 2002 Apr; 99(15):1729. PubMed ID: 12025205
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug information on better conditions].
    Rolfs M; Johansson P
    Lakartidningen; 2009 Mar 4-10; 106(10):655. PubMed ID: 19418682
    [No Abstract]   [Full Text] [Related]  

  • 14. [Marketing of inhalation steroids is more confusing than informative].
    Arnesen O
    Tidsskr Nor Laegeforen; 1994 Nov; 114(28):3360. PubMed ID: 7809900
    [No Abstract]   [Full Text] [Related]  

  • 15. [Whitewashing of drug information by the state].
    Reseland S
    Tidsskr Nor Laegeforen; 2010 Feb; 130(4):368. PubMed ID: 20220857
    [No Abstract]   [Full Text] [Related]  

  • 16. [Views on marketing of a neuroleptic agent].
    Bendz H
    Lakartidningen; 1999 Nov; 96(47):5191-2. PubMed ID: 10608107
    [No Abstract]   [Full Text] [Related]  

  • 17. [We don't receive sufficient information about calcium blockers and other drugs].
    Lindeberg S
    Lakartidningen; 1995 Oct; 92(43):3977. PubMed ID: 7475518
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physicians' travels abroad supported by drug industry scrutinized. Three cases surveyed by the IGM and the NBL].
    Perman E
    Lakartidningen; 2003 Dec; 100(51-52):4298-9. PubMed ID: 14756095
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reporting by the IGM (Information Inspection Team). Marketing of Clarityn disguised as an inquiry].
    Lakartidningen; 1996 Sep; 93(37):3168. PubMed ID: 8847942
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmaceutical consultants don't give neutral information].
    Reseland S
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2620. PubMed ID: 19023368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.